HK1257248A1 - 作為具有强的分化和抗增殖活性的組蛋白脫乙酰基酶抑制劑的苯甲酰胺衍生物 - Google Patents
作為具有强的分化和抗增殖活性的組蛋白脫乙酰基酶抑制劑的苯甲酰胺衍生物Info
- Publication number
- HK1257248A1 HK1257248A1 HK18116307.4A HK18116307A HK1257248A1 HK 1257248 A1 HK1257248 A1 HK 1257248A1 HK 18116307 A HK18116307 A HK 18116307A HK 1257248 A1 HK1257248 A1 HK 1257248A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- histone deacetylase
- deacetylase inhibitor
- proliferation activity
- benzamide derivative
- potent differentiation
- Prior art date
Links
- 230000001028 anti-proliverative effect Effects 0.000 title 1
- 150000003936 benzamides Chemical class 0.000 title 1
- 230000004069 differentiation Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 229940121372 histone deacetylase inhibitor Drugs 0.000 title 1
- 239000003276 histone deacetylase inhibitor Substances 0.000 title 1
- 230000003389 potentiating effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44791503P | 2003-02-14 | 2003-02-14 | |
US10/770,035 US7244751B2 (en) | 2003-02-14 | 2004-02-02 | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1257248A1 true HK1257248A1 (zh) | 2019-10-18 |
Family
ID=32872046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18116307.4A HK1257248A1 (zh) | 2003-02-14 | 2018-12-19 | 作為具有强的分化和抗增殖活性的組蛋白脫乙酰基酶抑制劑的苯甲酰胺衍生物 |
Country Status (14)
Country | Link |
---|---|
US (2) | US7244751B2 (zh) |
EP (3) | EP3336078A1 (zh) |
JP (1) | JP4637821B2 (zh) |
AU (1) | AU2004212345B2 (zh) |
CA (1) | CA2511479C (zh) |
CY (1) | CY1120141T1 (zh) |
DK (1) | DK2860174T3 (zh) |
ES (1) | ES2663274T3 (zh) |
HK (1) | HK1257248A1 (zh) |
HU (1) | HUE036127T2 (zh) |
PT (1) | PT2860174T (zh) |
RU (1) | RU2364589C2 (zh) |
SI (1) | SI2860174T1 (zh) |
WO (1) | WO2004071400A2 (zh) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6897220B2 (en) | 2001-09-14 | 2005-05-24 | Methylgene, Inc. | Inhibitors of histone deacetylase |
CN101851173A (zh) | 2001-09-14 | 2010-10-06 | 梅特希尔基因公司 | 组蛋白脱乙酰化酶抑制剂 |
US7868204B2 (en) | 2001-09-14 | 2011-01-11 | Methylgene Inc. | Inhibitors of histone deacetylase |
DK1485354T3 (da) | 2002-03-13 | 2008-09-01 | Janssen Pharmaceutica Nv | Sulfonylamino-derivater som nye inhibitorer af histandeacetylase |
NZ534831A (en) | 2002-03-13 | 2007-01-26 | Janssen Pharmaceutica Nv | Carbonylamino-derivatives having histone deacetylase (HDAC) inhibiting enzymatic activity |
AU2003212335B8 (en) | 2002-03-13 | 2009-04-23 | Janssen Pharmaceutica N.V. | Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
BR0307606A (pt) | 2002-03-13 | 2004-12-21 | Janssen Pharmaceutica Nv | Derivados de piperazinila, piperidinila e morfolinila como inibidores de histona desacetilase |
US7868205B2 (en) | 2003-09-24 | 2011-01-11 | Methylgene Inc. | Inhibitors of histone deacetylase |
US7253204B2 (en) | 2004-03-26 | 2007-08-07 | Methylgene Inc. | Inhibitors of histone deacetylase |
WO2006010750A1 (en) | 2004-07-28 | 2006-02-02 | Janssen Pharmaceutica N.V. | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
NZ599464A (en) | 2005-02-03 | 2014-03-28 | Topotarget Uk Ltd | Combination therapies using hdac inhibitors |
US7604939B2 (en) * | 2005-03-01 | 2009-10-20 | The Regents Of The University Of Michigan | Methods of identifying active BRM expression-promoting HDAC inhibitors |
US20100087328A1 (en) * | 2005-03-01 | 2010-04-08 | The Regents Of The University Of Michigan | Brm expression and related diagnostics |
GB0509225D0 (en) | 2005-05-05 | 2005-06-15 | Chroma Therapeutics Ltd | Inhibitors of enzymatic activity |
JP5108750B2 (ja) | 2005-05-13 | 2012-12-26 | トポターゲット ユーケー リミテッド | Hdac阻害剤の医薬製剤 |
EP1885710B1 (en) | 2005-05-18 | 2015-08-19 | Janssen Pharmaceutica N.V. | Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase |
CN101263121A (zh) | 2005-07-14 | 2008-09-10 | 塔克达圣地亚哥公司 | 组蛋白脱乙酰基酶抑制剂 |
WO2007054719A2 (en) | 2005-11-10 | 2007-05-18 | Topotarget Uk Limited | Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent |
JP5137849B2 (ja) | 2006-01-19 | 2013-02-06 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒストンデアセチラーゼのインヒビターとしての置換インドリル−アルキル−アミノ−誘導体 |
AU2007206942B2 (en) | 2006-01-19 | 2012-08-23 | Janssen Pharmaceutica N.V. | Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
AU2007206944B2 (en) | 2006-01-19 | 2012-08-23 | Janssen Pharmaceutica N.V. | Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
SI1981874T1 (sl) | 2006-01-19 | 2009-10-31 | Janssen Pharmaceutica Nv | Aminofenilni derivati kot novi inhibitorji histon deacetilaze |
AU2007206948B2 (en) | 2006-01-19 | 2012-08-23 | Janssen Pharmaceutica N.V. | Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
US7834011B2 (en) | 2006-01-19 | 2010-11-16 | Janssen Pharmaceutica N.V. | Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase |
AU2007234843B2 (en) | 2006-04-07 | 2013-07-11 | Methylgene Inc. | Inhibitors of histone deacetylase |
MX2010003230A (es) | 2007-09-25 | 2010-04-07 | Topotarget Uk Ltd | Metodos para la sintesis de ciertos compuestos de acido hidroxamico. |
US8476255B2 (en) | 2007-10-10 | 2013-07-02 | Orchid Chemicals & Pharmaceuticals Limited | Histone deacetylase inhibitors |
BRPI0817860A2 (pt) * | 2007-10-22 | 2019-09-24 | Orchid Res Laboratories Limited | inibidores de histona deacetilase |
US20110044952A1 (en) * | 2007-11-27 | 2011-02-24 | Ottawa Health Research Institute | Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors |
WO2009076206A1 (en) * | 2007-12-07 | 2009-06-18 | University Of Maryland, Baltimore | Synthesis methods of histone deacetylase inhibitors (hdacis) |
WO2009079375A1 (en) * | 2007-12-14 | 2009-06-25 | Georgetown University | Histone deacetylase inhibitors |
WO2010036404A2 (en) * | 2008-05-09 | 2010-04-01 | University Of Maryland, Baltimore | Novel retinamide retinoic acid metabolism blocking agents |
EP2285376A4 (en) * | 2008-05-16 | 2011-07-20 | Chipscreen Biosciences Ltd | 6-AMINONICOTINAMIDE DERIVATIVES FORMING POWERFUL AND SELECTIVE HISTONE DEACETYLASE INHIBITORS |
US8623853B2 (en) | 2008-07-23 | 2014-01-07 | The Brigham And Women's Hospital, Inc. | Treatment of cancers characterized by chromosomal rearrangement of the NUT gene |
WO2010028192A1 (en) | 2008-09-03 | 2010-03-11 | Repligen Corporation | Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors |
IT1392908B1 (it) | 2008-09-29 | 2012-04-02 | Italfarmaco Spa | Uso degli inibitori delle istone-deacetilasi per la cura di sindromi mieloproliferative philadelphia-negative |
WO2010130178A1 (zh) * | 2009-05-12 | 2010-11-18 | Sun Shuping | 丙烯酰胺类衍生物及其制备药物的用途 |
US8217079B2 (en) | 2010-03-26 | 2012-07-10 | Italfarmaco Spa | Method for treating Philadelphia-negative myeloproliferative syndromes |
CN102249958B (zh) * | 2010-11-29 | 2014-06-04 | 江苏先声药物研究有限公司 | 苯甲酰氨类组蛋白去乙酰化酶抑制剂 |
US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
DK2680694T3 (en) | 2011-02-28 | 2019-03-25 | Biomarin Pharm Inc | HISTONDEACETYLASE INHIBITORS |
EP2712655B1 (en) | 2011-04-28 | 2019-12-18 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
US9790184B2 (en) | 2012-07-27 | 2017-10-17 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
CN103833626B (zh) | 2012-11-27 | 2015-11-25 | 深圳微芯生物科技有限责任公司 | 西达本胺的晶型及其制备方法与应用 |
WO2014100438A1 (en) | 2012-12-20 | 2014-06-26 | The Broad Institute, Inc. | Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
CA2903490C (en) | 2013-03-15 | 2021-04-13 | Biomarin Pharmaceutical Inc. | Hdac inhibitors |
ES2862126T3 (es) * | 2013-10-10 | 2021-10-07 | Acetylon Pharmaceuticals Inc | Compuestos de pirimidín-hidroxiamida como inhibidores de histona desacetilasa |
US9988343B2 (en) | 2013-11-05 | 2018-06-05 | Dana-Farber Cancer Institute, Inc. | Inhibitors of histone deacetylase |
CN104771363A (zh) * | 2014-01-14 | 2015-07-15 | 深圳微芯生物科技有限责任公司 | 一种西达本胺固体分散体及其制备方法与应用 |
CN103880736B (zh) * | 2014-04-04 | 2017-05-17 | 深圳微芯生物科技有限责任公司 | 一种e构型苯甲酰胺类化合物及其药用制剂与应用 |
BR112017000301A2 (pt) | 2014-07-07 | 2017-11-07 | Acetylon Pharmaceuticals Inc | tratamento de leucemia com inibidores de histona desacetilase |
WO2016117666A1 (ja) | 2015-01-23 | 2016-07-28 | 国立大学法人鹿児島大学 | Hiv-1感染細胞殺傷剤及びその用途 |
ITUB20155193A1 (it) | 2015-11-03 | 2017-05-03 | Italfarmaco Spa | Sospensioni orali di Givinostat fisicamente e chimicamente stabili |
US10059668B2 (en) | 2015-11-05 | 2018-08-28 | Mirati Therapeutics, Inc. | LSD1 inhibitors |
JP6916795B2 (ja) | 2015-12-29 | 2021-08-11 | ミラティ セラピューティクス, インコーポレイテッド | Lsd1阻害剤 |
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
WO2018054960A1 (en) | 2016-09-21 | 2018-03-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting and treating resistance to chemotherapy in npm-alk(+) alcl |
CN107337671A (zh) * | 2016-12-31 | 2017-11-10 | 陕西科技大学 | 一类具有抗肿瘤活性的橙皮素氮杂肉桂酸酯化合物及其制备方法 |
US20190046513A1 (en) | 2017-08-10 | 2019-02-14 | Huya Bioscience International, Llc | Combination therapies of hdac inhibitors and tubulin inhibitors |
US11878009B2 (en) | 2019-09-10 | 2024-01-23 | Great Novel Therapeutics Biotech & Medicals Corporation | Anticancer combination of chidamide and celecoxib salts |
AU2021333655A1 (en) * | 2020-08-25 | 2023-05-04 | Huyabio International, Llc | Methods and compositions for genetic modulation of tumor microenvironments |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4719232A (en) * | 1985-12-20 | 1988-01-12 | Warner-Lambert Company | Benzoic acid and benzoic acid ester derivatives to treat headaches |
US5958792A (en) * | 1995-06-07 | 1999-09-28 | Chiron Corporation | Combinatorial libraries of substrate-bound cyclic organic compounds |
US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
JP3354090B2 (ja) * | 1996-09-30 | 2002-12-09 | シエーリング アクチエンゲゼルシャフト | 分化誘導剤 |
JPH10330254A (ja) * | 1997-04-01 | 1998-12-15 | Kissei Pharmaceut Co Ltd | 翼状片の進行および術後の再発抑制剤 |
US6313153B1 (en) * | 1997-07-25 | 2001-11-06 | Tsumura & Co. | Compositions and methods for treating nephritis and inhibiting TGF -β related conditions using pyridylacrylamide derivatives |
JP4405602B2 (ja) * | 1998-04-16 | 2010-01-27 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | ヒストン脱アセチル化酵素阻害剤 |
JP2000256194A (ja) * | 1999-01-06 | 2000-09-19 | Mitsui Chemicals Inc | 核内レセプタ作動薬およびその効果増強剤 |
AU3757600A (en) | 1999-03-19 | 2000-10-09 | Vertex Pharmaceuticals Incorporated | Oral low dose butyrate compositions |
JP2001081031A (ja) * | 1999-08-30 | 2001-03-27 | Schering Ag | 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤 |
EA007649B1 (ru) | 1999-09-08 | 2006-12-29 | Слоан-Кеттеринг Инститьют Фор Кэнсер Рисёч | Ингибиторы гистондеацетилазы, вызывающие дифференцировку клеток, и их применение |
AU2001248701A1 (en) | 2000-03-24 | 2001-10-03 | Methylgene, Inc. | Inhibitors of histone deacetylase |
EP1170008A1 (en) | 2000-07-07 | 2002-01-09 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Valproic acid and derivatives thereof as histone deacetylase inhibitors |
EP1598067B1 (en) | 2000-09-29 | 2009-05-06 | TopoTarget UK Limited | Carbamic acid compounds comprising an amide linkage for the treatment of malaria |
US20020103192A1 (en) * | 2000-10-26 | 2002-08-01 | Curtin Michael L. | Inhibitors of histone deacetylase |
-
2004
- 2004-02-02 US US10/770,035 patent/US7244751B2/en active Active
- 2004-02-09 EP EP17200696.7A patent/EP3336078A1/en active Pending
- 2004-02-09 EP EP14166931.7A patent/EP2860174B1/en not_active Expired - Lifetime
- 2004-02-09 CA CA2511479A patent/CA2511479C/en not_active Expired - Lifetime
- 2004-02-09 SI SI200432428T patent/SI2860174T1/en unknown
- 2004-02-09 EP EP04709299A patent/EP1592665A4/en not_active Ceased
- 2004-02-09 AU AU2004212345A patent/AU2004212345B2/en not_active Expired
- 2004-02-09 RU RU2005128550/04A patent/RU2364589C2/ru active
- 2004-02-09 ES ES14166931.7T patent/ES2663274T3/es not_active Expired - Lifetime
- 2004-02-09 JP JP2006502441A patent/JP4637821B2/ja not_active Expired - Lifetime
- 2004-02-09 WO PCT/IB2004/000401 patent/WO2004071400A2/en active Application Filing
- 2004-02-09 DK DK14166931.7T patent/DK2860174T3/en active
- 2004-02-09 PT PT141669317T patent/PT2860174T/pt unknown
- 2004-02-09 HU HUE14166931A patent/HUE036127T2/hu unknown
-
2007
- 2007-07-11 US US11/776,477 patent/US7550490B2/en not_active Expired - Lifetime
-
2018
- 2018-02-27 CY CY20181100243T patent/CY1120141T1/el unknown
- 2018-12-19 HK HK18116307.4A patent/HK1257248A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US7244751B2 (en) | 2007-07-17 |
WO2004071400A2 (en) | 2004-08-26 |
US20080039509A1 (en) | 2008-02-14 |
WO2004071400A3 (en) | 2005-06-16 |
RU2364589C2 (ru) | 2009-08-20 |
CY1120141T1 (el) | 2018-12-12 |
AU2004212345A1 (en) | 2004-08-26 |
US20040224991A1 (en) | 2004-11-11 |
PT2860174T (pt) | 2018-03-06 |
SI2860174T1 (en) | 2018-04-30 |
EP2860174A2 (en) | 2015-04-15 |
US7550490B2 (en) | 2009-06-23 |
AU2004212345B2 (en) | 2009-07-23 |
CA2511479C (en) | 2012-04-24 |
CA2511479A1 (en) | 2004-08-26 |
HUE036127T2 (hu) | 2018-06-28 |
EP1592665A4 (en) | 2007-07-18 |
JP2007527362A (ja) | 2007-09-27 |
EP2860174B1 (en) | 2017-11-29 |
EP1592665A2 (en) | 2005-11-09 |
DK2860174T3 (en) | 2018-03-12 |
ES2663274T3 (es) | 2018-04-11 |
EP3336078A1 (en) | 2018-06-20 |
RU2005128550A (ru) | 2006-01-20 |
EP2860174A3 (en) | 2015-07-08 |
JP4637821B2 (ja) | 2011-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1257248A1 (zh) | 作為具有强的分化和抗增殖活性的組蛋白脫乙酰基酶抑制劑的苯甲酰胺衍生物 | |
EG25655A (en) | Benzamide derivatives useful as histone deacetylase inhibitors | |
PL374970A1 (en) | Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors | |
IL164002A0 (en) | Sulfonyl-derivatives as novel inhibitors of histone deacetylase | |
IL164003A0 (en) | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase | |
HK1080465A1 (zh) | 作為組蛋白脫乙酰酶新穎抑制劑的磺酰基氨基衍生物 | |
HK1072365A1 (en) | Inhibitors of histone deacetylase | |
SI1208086T1 (sl) | Benzamidna formulacija s histon deacetilazno inhibitorsko aktivnostjo | |
AU2003215112A8 (en) | Novel bicyclic hydroxamates as inhibitors of histone deacetylase | |
AU2003219595A8 (en) | Alpha,beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors | |
PL378181A1 (pl) | Pochodne kwasu hydroksamidowego jako inhibitory deacetylazy histonowej (HDAC) | |
AU2003221786A1 (en) | Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors | |
AU2003286249A8 (en) | Histone deacetylase inhibitors | |
EP2089354A4 (en) | NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING HISTONE DEACETYLASE INHIBITORY ACTIVITY AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
EP1945606A4 (en) | ALKYLCARBAMOYLNAPHTALENYLOXYOCTENOYLHYDROXYAMIDE DERIVATIVES HAVING HISTONE DEACETYLASE INHIBITORY ACTIVITY AND SYNTHESIS OF THE DERIVATIVES | |
EP1408946A4 (en) | HISTONE DEACETYLASE INHIBITORS | |
AU2003300800A1 (en) | Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors | |
AU2003277878A1 (en) | Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors | |
HK1079042A2 (en) | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity | |
TWI346661B (en) | Inhibitors of histone deacetylase | |
ZA200706012B (en) | N-sulphonylpyrroles and their use as histone deacetylase inhibitors |